StockData
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) stock

MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.57−0.33 (-4.78%)

Close on Nov 17, 2026Market cap $304.70MP/E –Yield –

MapLight Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

MapLight Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$174.67M. For fiscal 2025 it was -$138.14M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$138.14M–
FY2024Dec 31, 2024-$78.82M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$44.87M–
Q1 FY2026Mar 31, 2026-$51.18M–
Q4 FY2025Dec 31, 2025-$46.83M–
Q3 FY2025Sep 30, 2025-$31.79M–
Q2 FY2025Jun 30, 2025-$33.97M–
Q1 FY2025Mar 31, 2025-$25.55M–
Q4 FY2024Dec 31, 2024-$21.49M–

More MapLight Therapeutics figures

See a number that looks wrong?